CLOROX COMPANY (CLX) Fundamental Analysis & Valuation

NYSE:CLX • US1890541097

Current stock price

105.28 USD
-2.34 (-2.17%)
At close:
106.25 USD
+0.97 (+0.92%)
After Hours:

This CLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CLX Profitability Analysis

1.1 Basic Checks

  • CLX had positive earnings in the past year.
  • CLX had a positive operating cash flow in the past year.
  • CLX had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CLX had a positive operating cash flow.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • With an excellent Return On Assets value of 13.45%, CLX belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
  • The Return On Invested Capital of CLX (21.55%) is better than 83.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLX is above the industry average of 14.94%.
  • The last Return On Invested Capital (21.55%) for CLX is above the 3 year average (18.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROIC 21.55%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

  • CLX has a better Profit Margin (11.17%) than 66.67% of its industry peers.
  • CLX's Profit Margin has declined in the last couple of years.
  • CLX has a Operating Margin (15.21%) which is comparable to the rest of the industry.
  • CLX's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 44.16%, CLX is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CLX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CLX is creating value.
  • CLX has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CLX has been reduced compared to 5 years ago.
  • CLX has a worse debt/assets ratio than last year.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.08 indicates that CLX is not in any danger for bankruptcy at the moment.
  • With a Altman-Z score value of 3.08, CLX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • CLX has a debt to FCF ratio of 3.59. This is a good value and a sign of high solvency as CLX would need 3.59 years to pay back of all of its debts.
  • CLX's Debt to FCF ratio of 3.59 is in line compared to the rest of the industry. CLX outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Altman-Z 3.08
ROIC/WACC2.71
WACC7.95%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 0.74 indicates that CLX may have some problems paying its short term obligations.
  • CLX has a Current ratio of 0.74. This is amonst the worse of the industry: CLX underperforms 83.33% of its industry peers.
  • CLX has a Quick Ratio of 0.74. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.48, CLX is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.48
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CLX Growth Analysis

3.1 Past

  • CLX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.48%.
  • Measured over the past 5 years, CLX shows a small growth in Earnings Per Share. The EPS has been growing by 1.01% on average per year.
  • Looking at the last year, CLX shows a decrease in Revenue. The Revenue has decreased by -5.68% in the last year.
  • Measured over the past years, CLX shows a small growth in Revenue. The Revenue has been growing by 1.11% on average per year.
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.95% on average over the next years.
  • Based on estimates for the next years, CLX will show a small growth in Revenue. The Revenue will grow by 1.34% on average per year.
EPS Next Y-22.64%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
EPS Next 5Y2.95%
Revenue Next Year-7.75%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.94%
Revenue Next 5Y1.34%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.05, CLX is valued correctly.
  • CLX's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.78. CLX is valued slightly cheaper when compared to this.
  • A Price/Forward Earnings ratio of 15.29 indicates a correct valuation of CLX.
  • CLX's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. CLX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.05
Fwd PE 15.29
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as CLX.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as CLX.
Industry RankSector Rank
P/FCF 16.36
EV/EBITDA 12.21
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The decent profitability rating of CLX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)15.84
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

8

5. CLX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.86%, CLX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.83, CLX pays a better dividend. On top of this CLX pays more dividend than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.86%

5.2 History

  • The dividend of CLX has a limited annual growth rate of 2.88%.
  • CLX has paid a dividend for at least 10 years, which is a reliable track record.
  • CLX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • 79.74% of the earnings are spent on dividend by CLX. This is not a sustainable payout ratio.
  • CLX's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP79.74%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CLX Fundamentals: All Metrics, Ratios and Statistics

CLOROX COMPANY

NYSE:CLX (4/10/2026, 8:13:57 PM)

After market: 106.25 +0.97 (+0.92%)

105.28

-2.34 (-2.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)02-03
Earnings (Next)05-04
Inst Owners84.93%
Inst Owner Change0%
Ins Owners0.41%
Ins Owner Change-0.21%
Market Cap12.73B
Revenue(TTM)6.76B
Net Income(TTM)755.00M
Analysts55.56
Price Target126.88 (20.52%)
Short Float %6.11%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 4.86%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP79.74%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-22
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.49%
Min EPS beat(2)-3.99%
Max EPS beat(2)6.97%
EPS beat(4)2
Avg EPS beat(4)5.85%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)6
Avg EPS beat(8)12.97%
EPS beat(12)10
Avg EPS beat(12)48.42%
EPS beat(16)13
Avg EPS beat(16)42.93%
Revenue beat(2)2
Avg Revenue beat(2)0.98%
Min Revenue beat(2)0.9%
Max Revenue beat(2)1.06%
Revenue beat(4)3
Avg Revenue beat(4)-0.19%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)1.58%
Revenue beat(8)5
Avg Revenue beat(8)0.09%
Revenue beat(12)9
Avg Revenue beat(12)2.15%
Revenue beat(16)11
Avg Revenue beat(16)1.6%
PT rev (1m)0%
PT rev (3m)1.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.54%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 16.05
Fwd PE 15.29
P/S 1.88
P/FCF 16.36
P/OCF 12.94
P/B N/A
P/tB N/A
EV/EBITDA 12.21
EPS(TTM)6.56
EY6.23%
EPS(NY)6.88
Fwd EY6.54%
FCF(TTM)6.43
FCFY6.11%
OCF(TTM)8.14
OCFY7.73%
SpS55.89
BVpS-1.03
TBVpS-15.81
PEG (NY)N/A
PEG (5Y)15.84
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.45%
ROE N/A
ROCE 31.48%
ROIC 21.55%
ROICexc 23.01%
ROICexgc 49.39%
OM 15.21%
PM (TTM) 11.17%
GM 44.16%
FCFM 11.51%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.59
Debt/EBITDA 2.23
Cap/Depr 92.38%
Cap/Sales 3.05%
Interest Coverage 250
Cash Conversion 78.66%
Profit Quality 103.05%
Current Ratio 0.74
Quick Ratio 0.48
Altman-Z 3.08
F-Score6
WACC7.95%
ROIC/WACC2.71
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
EPS Next Y-22.64%
EPS Next 2Y-5.63%
EPS Next 3Y-1.72%
EPS Next 5Y2.95%
Revenue 1Y (TTM)-5.68%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%
Revenue Next Year-7.75%
Revenue Next 2Y-0.35%
Revenue Next 3Y0.94%
Revenue Next 5Y1.34%
EBIT growth 1Y-2.93%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year6.04%
EBIT Next 3Y8.42%
EBIT Next 5Y7.05%
FCF growth 1Y6.87%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y4.24%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 5 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 4 / 10 to CLOROX COMPANY (CLX). This can be considered as Fairly Valued.


How profitable is CLOROX COMPANY (CLX) stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CLOROX COMPANY?

The Earnings per Share (EPS) of CLOROX COMPANY (CLX) is expected to decline by -22.64% in the next year.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 8 / 10 and the dividend payout ratio is 79.74%.